2000
1. Lasek W. Immunologia - Repetytorium. Wydawnictwo Naukowe PWN, Warszawa 2000. (podręczn.)
2. Gołąb J. Interleukin-18 - interferon-g-inducing factor (IGIF) - a novel player in cancer immunotherapy? Cytokine 2000; 12: 332-338. (przegląd.)
3. Gołąb J, Stokłosa T, Czajka A, Dąbrowska A, Jakóbisiak M., Zagożdżon R, Wójcik C, Marczak M., Wilk S. Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice. Anticancer Res 2000; 20: 1717-1721. (eksper.)
4. Gołąb J, Zagżodżon R, Stokłosa T, Kamiński R, Kozar K, Jakóbisiak M. Direct stimulation of macrophages by IL-12 and IL-18 - a bridge too far? Immunol Lett 2000; 72: 153-157. (eksper.)
5. Ostrowska H, Wójcik C, Wilk S, Omura S, Kozłowski L, Stokłosa T, Worowski K, Radziwon P. Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome. Int J Biochem Cell Biol. 2000; 32: 747-757. (eksper.)
6. Feleszko W, Młynarczuk I, Bałkowiec-Iskra EZ, Czajka A, Świtaj T, Stokłosa T, Giermasz A, Jakóbisiak M. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice. Clin Cancer Res. 2000; 6: 2044-2052. (eksper.)
7. Feleszko W, Jakóbisiak M. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res. 2000; 6: 1198-1199. (eksper.)
8. Gołąb J, Wilczynski GM, Zagożdżon R, Stokłosa T, Dąbrowska A, Rybczynska J, Wasik M, Machaj E, Ołdak T, Kozar K, Kaminski R, Giermasz A, Czajka A, Lasek W, Feleszko W, Jakóbisiak M. Potentiation of the antitumor effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Brit J Cancer 2000; 8: 1485-1491. (eksper.)
9. Dąbrowska A, Giermasz A, Marczak M, Gołąb J, Jakóbisiak M. Potentiated antitumor effects of interleukin 12 and matrix metalloproteinase inhibitor batimastat against B16 F10 melanoma in mice. Anticancer Res 2000; 220:391-394. (eksper.)
10. Gołąb J, Kozar K, Kaminski R, Czajka A, Marczak M, Świtaj T, Giermasz A, Stokłosa T, Lasek W, Zagożdżon R, Mucha K, Jakóbisiak M. Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice. Life Sci 2000; 66: 1223-1230. (eksper.)
11. Gołąb J, Zagożdżon R, Kozar K, Kamiński R, Giermasz A, Stokłosa T, Lasek W, Jakóbisiak M. Potentiated antitumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo. Oncol Rep 2000; 7: 177-181. (eksper.)
12. Gołąb J, Zagożdżon R, Kozar K, Kaminski R, Giermasz A, Stokłosa T, Lasek W, Jakóbisiak M. Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo. Oncol Rep. 2000; 7:177-81. (eksper.)
13. Lasek W, Mackiewicz A, Czajka A, Świtaj T, Gołąb J, Wiznerowicz M, Korczak-Kowalska G, Bałkowiec-Iskra EZ, Gryska K, Iżycki D, Jakóbisiak M. Antitumor effects of the combination therapy with TNF-alpha gene-modified tumor cells and interleukin 12 in a melanoma model in mice. Cancer Gene Ther. 2000; 7: 1581-1590. (eksper.)
14. Wójcik C, Bury M, Stokłosa T, Giermasz A, Feleszko W, Młynarczuk I, Pleban E, Basak G, Omura S, Jakóbisiak M. Lovastatin and simvastatin are modulators of the proteasome. Int J Biochem Cell Biol. 2000; 32: 957-965. (eksper.)